A Bioequivalence Study of a New Paracetamol Oral Suspension 24mg/ml Compared to the Marketed Paracetamol Oral Suspension (Panadol Baby and Infant 24mg/ml) in Healthy Adult Subjects
Clinical trial NCT05022810 · COMPLETED
Trial details
- NCT number
- NCT05022810
- Sponsor
- HALEON
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-23
- Primary completion
- 2021-09-08
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.